KR840008279A - 아미노산 함유지방유제의 지방미립자화 방법 - Google Patents

아미노산 함유지방유제의 지방미립자화 방법 Download PDF

Info

Publication number
KR840008279A
KR840008279A KR1019840002093A KR840002093A KR840008279A KR 840008279 A KR840008279 A KR 840008279A KR 1019840002093 A KR1019840002093 A KR 1019840002093A KR 840002093 A KR840002093 A KR 840002093A KR 840008279 A KR840008279 A KR 840008279A
Authority
KR
South Korea
Prior art keywords
amino acid
lysine
acyl
fat emulsion
containing fat
Prior art date
Application number
KR1019840002093A
Other languages
English (en)
Other versions
KR910002637B1 (ko
Inventor
히로사찌 오바시 (외 4)
Original Assignee
우따다 가쓰히로
아지노모도 가부시기 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우따다 가쓰히로, 아지노모도 가부시기 가이샤 filed Critical 우따다 가쓰히로
Publication of KR840008279A publication Critical patent/KR840008279A/ko
Application granted granted Critical
Publication of KR910002637B1 publication Critical patent/KR910002637B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음.

Description

아미노산 함유지방유제의 지방미립자화 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 아미노산 함유 지방유제의 제조에 있어서, 아미노산중에 시트르, N-린아실아르기닌 및 N-아실오르니틴의 적어도 한종류를 혼합 함유시킴을 특징으로 하는 지방의 미립자화방법.
  2. 제1항에 있어서, 아미노산중에 리신을 적어도 N-아실체의 형으로 혼합함유시킴을 특징으로 하는 방법.
  3. 제1항이 있어서, 아미노산중에 리신을 적어도 유기산염의 형으로 혼합시킴을 특징으로하는 방법.
  4. 제1항에 있어서, 아미노산이 스레오닌, 세린, 프로린, 글리신, 아라닌, 바린, 메티오닌, 이소로이신로이신, 트립토판, 페닐아라닌, 히스티딘, 리시 또는 그의 수식체(修飾體), 시트르린 및 시스틴을 함유하는 것인 방법.
  5. 제1항에 있어서, 아미노산 함량이 1 내지 15%인 방법.
  6. 제1항에 있어서, 지방함량이 1 내지 15%인 방법.
  7. 제2항에 있어서, 리신의 N-아실체 농도가 4×10-3내지 5×l0-4%(mole/v)인 방법.
  8. 제3항에 있어서, 리신의 유기산염 농도가 4×10-3내지 5×10-4%(mole/v)인 방법.
  9. 제1항에 있어서, 탄수화물을 함유하는 방법.
  10. 제9항에 있어서, 탄수화물이 소르비톨, 키실리톨 및 글리세린의 적어도 한종류를 함유하는 것인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840002093A 1983-04-20 1984-04-20 아미노산 함유지방유제의 지방미립자화 방법 KR910002637B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP58069712A JPS59193814A (ja) 1983-04-20 1983-04-20 アミノ酸含有脂肪乳剤
JP69712 1983-04-20
JP58-69712 1983-04-20

Publications (2)

Publication Number Publication Date
KR840008279A true KR840008279A (ko) 1984-12-14
KR910002637B1 KR910002637B1 (ko) 1991-04-27

Family

ID=13410717

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840002093A KR910002637B1 (ko) 1983-04-20 1984-04-20 아미노산 함유지방유제의 지방미립자화 방법

Country Status (7)

Country Link
EP (1) EP0144434A4 (ko)
JP (1) JPS59193814A (ko)
KR (1) KR910002637B1 (ko)
CA (1) CA1217725A (ko)
IT (1) IT1176120B (ko)
WO (1) WO1984004244A1 (ko)
ZA (1) ZA842129B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6217A (ja) * 1985-02-14 1987-01-06 Chugai Pharmaceut Co Ltd 安定な活性型ビタミンｄ３類製剤
IL78929A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Microemulsion compositions for parenteral administration
SE8505047L (sv) * 1985-10-25 1987-04-26 Nutritional Int Res Inst Fettemulsion
US5684050A (en) * 1986-01-24 1997-11-04 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5514720A (en) * 1986-07-09 1996-05-07 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
JP2643217B2 (ja) * 1988-01-22 1997-08-20 エーザイ株式会社 脂溶性物質水性液
US5171755A (en) * 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
AU651738B2 (en) * 1991-10-07 1994-07-28 Otsuka Pharmaceutical Factory, Inc. Enteral preparation for cancer therapy
US5403575A (en) * 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
EP0988857B8 (en) 1998-08-31 2006-05-03 Nipro Corporation Nutrient infusion preparation
KR100459025B1 (ko) * 2002-05-02 2004-12-03 (주) 에프디엘 프로포폴을 함유하는 신규한 주사제용 조성물
DE102009034115A1 (de) * 2009-07-20 2011-01-27 Beiersdorf Ag Kosmetische Zubereitung mit einem Gehalt an Acylarginaten

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2850387A (en) * 1955-01-27 1958-09-02 Schwarz Lab Inc Alpha-amino acid derivative and fats and oils containing same
DE1792034A1 (de) * 1964-09-28 1971-10-07 Yamanouchi Pharma Co Ltd Verwendung von Glutathion-Aminosaeure-Gemischen als Leberschutzmittel fuer Mensch und Tier
FR6475M (ko) * 1967-05-31 1968-11-18
DE1792294B1 (de) * 1968-08-16 1970-07-09 Braun Fa B Verfahren zur Herstellung stabiler,nicht pyrogener,intravenoes applizierbarer,waessriger aminosaeurehaltiger Fettemulsionen
DE2111361B2 (de) * 1971-03-10 1973-02-15 Verwendung von n-acylaminosaeuren, deren salzen und/oder estern als emulgatoren
JPS5810365B2 (ja) * 1978-09-08 1983-02-25 田辺製薬株式会社 脂肪乳剤
US4499067A (en) * 1982-08-26 1985-02-12 Johnson & Johnson Products, Inc. Oral compositions comprising NG -acyl derivatives of arginine

Also Published As

Publication number Publication date
EP0144434A4 (en) 1985-09-02
JPH0463049B2 (ko) 1992-10-08
EP0144434A1 (en) 1985-06-19
CA1217725A (en) 1987-02-10
IT8420670A0 (it) 1984-04-20
ZA842129B (en) 1984-10-31
IT8420670A1 (it) 1985-10-20
IT1176120B (it) 1987-08-12
JPS59193814A (ja) 1984-11-02
WO1984004244A1 (en) 1984-11-08
KR910002637B1 (ko) 1991-04-27

Similar Documents

Publication Publication Date Title
KR840008279A (ko) 아미노산 함유지방유제의 지방미립자화 방법
KR910004199A (ko) 수성 이고제형 제약 조성물
ATE77391T1 (de) Peptide.
KR920019371A (ko) 안정화된 인자 ⅷ 제제
ATE209864T1 (de) Zusammensetzung zur behandlung von patienten mit lebererkrankungen
KR890011586A (ko) 지용성물질의 수용액
JPS5536457A (en) Amino acid infusion
SE8505048D0 (sv) Nutritionsemulsion med syretransporterande egenskaper
DE3867445D1 (de) Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
DE3866045D1 (de) Arzneimittel zur behandlung von uraemie.
SE327779B (ko)
KR950024769A (ko) 고농도 tcf 제제
KR860006982A (ko) 안정한 감마 인터페론 제형의 제조방법
GB1232719A (ko)
ATE47518T1 (de) Injizierbare pharmazeutische zusammenstellungen die bestaendige 5-adenosyl-l-methionin-salze enthalten.
JPS57112367A (en) Preparation of stable aqueous solution of compound having thiol group
JPS57128635A (en) Pharmaceutical preparation of gamma-globulin for venoclysis
DE60141632D1 (de) Zusammensetzung zur stabilisierung von fettlöslichen vitaminen in wässeriger lösung
JPS56125313A (en) Remedy for damage
GB866423A (en) Improvements in or relating to chymotrypsin solutions
KR860003012A (ko) (-)시스-1,2-에폭시프로필포스폰산과 아미노산과의 염을 함유하는 수용성 제약 조성물
JPS5668374A (en) Food composition for hepatic insufficiency
GB1444621A (en) Composition for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy-acid analogues of amino acids
EP0063328A3 (en) Compositions containing secretin and method for preventing the adsorption of secretin
KR870009713A (ko) 파모티딘의 주사용 조성물의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19940319

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee